Venetoclax is a targeted therapy drug used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, and acute myeloid leukemia.
Category:
Medicine
-
-
Trastuzumab is a targeted therapy drug used to treat Her-2 positive breast cancer, and Her-2 positive metastatic stomach cancer.
-
-
-
-
Pertuzumab is a targeted therapy drug used to treat HER2-positive breast cancer in combination with trastuzumab (another Her-2 targeted therapy drug) and chemotherapy.
-
“Panitumumab is a targeted therapy drug used to treat metastatic colorectal cancer that shows EGFR mutations.”
-
Paclitaxel is a chemotherapy drug used to treat Breast cancer, Ovarian cancer, Cervical Cancer, Head and neck cancers, Upper GI cancers like esophagus and gastric cancers, Pancreatic cancer, Non-small cell lung cancer, and Kaposi’s sarcoma.
-
Ofatumumab is chemotherapy and targeted therapy drug which is available in two brand names Arzerra and Kesimpta. Arzerra is approved for Chronic lymphocytic leukemia whereas Kesimpta is approved for Relapsing multiple sclerosis.
-
Obinutuzumab is a targeted therapy drug used to treat Chronic Lymphocytic Leukemia and Follicular lymphoma.
